IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-alpha and DTIC. [electronic resource]
Producer: 20031218Description: 647-55 p. digitalISSN:- 0262-0898
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Dacarbazine -- therapeutic use
- Female
- Humans
- Interferon-alpha -- therapeutic use
- Interleukin-2 -- pharmacology
- Killer Cells, Natural -- immunology
- Lymphocyte Activation
- Lymphocyte Subsets -- immunology
- Male
- Melanoma -- drug therapy
- Middle Aged
- T-Lymphocytes -- immunology
- Tumor Necrosis Factor Receptor Superfamily, Member 7 -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.